These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 31441343)
1. Uncertainty managing patients treated with antiresorptive drugs: a cross-sectional study of attitudes and self-reported behavior among dentists in Sweden. Dahlgren M; Larsson Wexell C Acta Odontol Scand; 2020 Mar; 78(2):109-117. PubMed ID: 31441343 [No Abstract] [Full Text] [Related]
2. Knowledge, practices, and opinions of ontario dentists when treating patients receiving bisphosphonates. Alhussain A; Peel S; Dempster L; Clokie C; Azarpazhooh A J Oral Maxillofac Surg; 2015 Jun; 73(6):1095-105. PubMed ID: 25843818 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-related osteonecrosis of the jaw: awareness and level of knowledge of Lebanese physicians. El Osta L; El Osta B; Lakiss S; Hennequin M; El Osta N Support Care Cancer; 2015 Sep; 23(9):2825-31. PubMed ID: 25672288 [TBL] [Abstract][Full Text] [Related]
4. Knowledge and attitudes of French dentists on bone resorption inhibitors (bisphosphonates and denosumab): A cross-sectional study. Arnaud MP; Talibi S; Lejeune-Cairon S J Stomatol Oral Maxillofac Surg; 2022 Apr; 123(2):163-170. PubMed ID: 33930600 [TBL] [Abstract][Full Text] [Related]
5. Knowledge and attitude regarding bisphosphonates and related osteonecrosis among Turkish dentist: A cross sectional study. Ozkan E; Bereket MC; Ozkan N Niger J Clin Pract; 2021 Oct; 24(10):1485-1491. PubMed ID: 34657014 [TBL] [Abstract][Full Text] [Related]
6. Awareness About Medication-Related Osteonecrosis of the Jaw Among Dental Professionals: A Multicentre Study. Patil V; Acharya S; Vineetha R; Nikhil K Oral Health Prev Dent; 2020 Jul; 18(3):505-509. PubMed ID: 32016175 [TBL] [Abstract][Full Text] [Related]
7. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone. Shibahara T Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280 [TBL] [Abstract][Full Text] [Related]
8. Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab. Loyson T; Van Cann T; Schöffski P; Clement PM; Bechter O; Spriet I; Coropciuc R; Politis C; Vandeweyer RO; Schoenaers J; Dumez H; Berteloot P; Neven P; Nackaerts K; Woei-A-Jin FJSH; Punie K; Wildiers H; Beuselinck B Acta Clin Belg; 2018 Apr; 73(2):100-109. PubMed ID: 28693379 [TBL] [Abstract][Full Text] [Related]
9. Survey of Korean dentists on the awareness on bisphosphonate-related osteonecrosis of the jaws. Yoo JY; Park YD; Kwon YD; Kim DY; Ohe JY J Investig Clin Dent; 2010 Nov; 1(2):90-5. PubMed ID: 25427263 [TBL] [Abstract][Full Text] [Related]
10. Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review. Querrer R; Ferrare N; Melo N; Stefani CM; Dos Reis PED; Mesquita CRM; Borges GA; Leite AF; Figueiredo PT Support Care Cancer; 2021 Jun; 29(6):2811-2820. PubMed ID: 33140246 [TBL] [Abstract][Full Text] [Related]
11. The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey. Han AL BMC Oral Health; 2021 Mar; 21(1):155. PubMed ID: 33761923 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate-associated Osteonecrosis of the Jaws: a Survey of the Level of Knowledge of Dentists about the Risks of Bisphosphonate Therapy. Hristamyan-Cilev MA; Pechalova PP; Raycheva RD; Hristamyan VP; Kevorkyan AK; Stoilova YD Folia Med (Plovdiv); 2019 Jun; 61(2):303-311. PubMed ID: 31301653 [TBL] [Abstract][Full Text] [Related]
13. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors. Dodson TB Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367 [TBL] [Abstract][Full Text] [Related]
14. Antiresorptive drug-related osteonecrosis of the jaw. Uyanne J; Calhoun CC; Le AD Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528 [TBL] [Abstract][Full Text] [Related]
15. Paediatric Dentists Treating Children on Bisphosphonates: A Cross-Sectional Questionnaire-Based Study. Lau J; Ng L; Siddiqi A; Zafar S Pediatr Dent; 2019 Jul; 41(4):285-292. PubMed ID: 31439088 [No Abstract] [Full Text] [Related]
16. Antiresorptive treatment-associated ONJ. Eleutherakis-Papaiakovou E; Bamias A Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 29063702 [TBL] [Abstract][Full Text] [Related]
17. Drug-induced osteonecrosis of the jaw: the state of the art. Fassio A; Bertoldo F; Idolazzi L; Viapiana O; Rossini M; Gatti D Reumatismo; 2017 May; 69(1):9-15. PubMed ID: 28535616 [TBL] [Abstract][Full Text] [Related]
18. Medication-related osteonecrosis of the jaw: A survey of knowledge, attitudes, and practices among dentists in the principality of Asturias (Spain). Escobedo M; García-Consuegra L; Junquera S; Olay S; Ascani G; Junquera L J Stomatol Oral Maxillofac Surg; 2018 Nov; 119(5):395-400. PubMed ID: 29684638 [TBL] [Abstract][Full Text] [Related]
19. Impact of Osteonecrosis of the Jaw on Osteoporosis Treatment in Japan: Results of a Questionnaire-Based Survey by the Adequate Treatment of Osteoporosis (A-TOP) Research Group. Taguchi A; Shiraki M; Tsukiyama M; Miyazaki T; Soen S; Ohta H; Nakamura T; Orimo H Calcif Tissue Int; 2015 Dec; 97(6):542-50. PubMed ID: 26210799 [TBL] [Abstract][Full Text] [Related]
20. A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer. Schiodt M; Vadhan-Raj S; Chambers MS; Nicolatou-Galitis O; Politis C; Coropciuc R; Fedele S; Jandial D; Zhang J; Ma H; Saunders DP Support Care Cancer; 2018 Jun; 26(6):1905-1915. PubMed ID: 29275525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]